Skip to main content
RCEL
NASDAQ Life Sciences

Q3 Revenue Jumps 53% to $26.1M, Guidance Raised, Going Concern Warning Lifted

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$16.65
Mkt Cap
$484.933M
52W Low
$3.22
52W High
$16.9
52W Position info
417% above low
Off High info
1.5% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

RCEL has more than doubled off its 52-week low of $3.22.

Summary

AVITA posted Q3 revenue of $26.1M, up 53% year over year and 20% sequentially, with gross margin at 84.0% (up 270 bps). The company raised full-year 2026 revenue guidance to $92M-$94M from $86M-$89M and reaffirmed cash flow breakeven in Q4. Most importantly, management removed the going concern qualification that had hung over the story since the Q2 report, after hitting the $85M trailing-twelve-month revenue milestone and drawing the final $10M Perceptive tranche (total borrowings now $60M). Net cash use shrank to $0.6M from $3.2M in Q2, though cash and securities stood at just $10.5M at quarter-end. Separately, CMS finalized national physician payment values and simplified billing codes for RECELL effective January 1, 2027 — a reimbursement tailwind heading into next year. The stock is trading near its 52-week high of $16.90, so the bar was high; the guidance raise plus going-concern removal is the combination that matters.

At the time of this announcement, RCEL was trading at $16.65 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $484.9M. The 52-week trading range was $3.22 to $16.90. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

RCEL - Latest Insights

RCEL
Nov 16, 2026, 8:08 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $16.20
Real-time Price: $15.31 info
Change: -$0.890 (-5%) info
Market Cap: $490.784M info
RCEL
Nov 05, 2026, 4:15 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $17.70
Real-time Price: $15.31 info
Change: -$2.39 (-14%) info
Market Cap: $490.784M info
RCEL
Nov 05, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.91
Real-time Price: $15.31 info
Change: -$2.60 (-15%) info
Market Cap: $490.784M info
RCEL
Aug 18, 2026, 7:45 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $8.50
Real-time Price: $15.31 info
Change: +$6.81 (+80%) info
Market Cap: $490.784M info
RCEL
Aug 11, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.20
Real-time Price: $15.31 info
Change: +$7.11 (+87%) info
Market Cap: $490.784M info